Xponance’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-12,010
| Closed | -$105K | – | 1541 |
|
|
2025
Q1 | $105K | Buy |
12,010
+1,778
| +17% | +$15.5K | ﹤0.01% | 1344 |
|
|
2024
Q4 | $147K | Sell |
10,232
-181
| -2% | -$2.6K | ﹤0.01% | 1324 |
|
|
2024
Q3 | $235K | Buy |
10,413
+200
| +2% | +$4.52K | ﹤0.01% | 1171 |
|
|
2024
Q2 | $199K | Sell |
10,213
-1,418
| -12% | -$27.6K | ﹤0.01% | 1182 |
|
|
2024
Q1 | $437K | Sell |
11,631
-484
| -4% | -$18.2K | ﹤0.01% | 981 |
|
|
2023
Q4 | $678K | Sell |
12,115
-945
| -7% | -$52.9K | 0.01% | 820 |
|
|
2023
Q3 | $539K | Buy |
13,060
+400
| +3% | +$16.5K | 0.01% | 861 |
|
|
2023
Q2 | $707K | Buy |
12,660
+989
| +8% | +$55.2K | 0.01% | 775 |
|
|
2023
Q1 | $651K | Buy |
11,671
+454
| +4% | +$25.3K | 0.01% | 817 |
|
|
2022
Q4 | $409K | Buy |
11,217
+1,138
| +11% | +$41.5K | 0.01% | 954 |
|
|
2022
Q3 | $287K | Buy |
10,079
+558
| +6% | +$15.9K | 0.01% | 1006 |
|
|
2022
Q2 | $431K | Sell |
9,521
-20
| -0.2% | -$905 | 0.01% | 914 |
|
|
2022
Q1 | $726K | Sell |
9,541
-61
| -0.6% | -$4.64K | 0.01% | 725 |
|
|
2021
Q4 | $1.43M | Buy |
9,602
+223
| +2% | +$33.2K | 0.02% | 479 |
|
|
2021
Q3 | $1.37M | Sell |
9,379
-396
| -4% | -$57.6K | 0.03% | 452 |
|
|
2021
Q2 | $1.91M | Buy |
9,775
+3,771
| +63% | +$738K | 0.04% | 380 |
|
|
2021
Q1 | $1.09M | Buy |
6,004
+100
| +2% | +$18.1K | 0.02% | 456 |
|
|
2020
Q4 | $836K | Sell |
5,904
-48
| -0.8% | -$6.8K | 0.02% | 519 |
|
|
2020
Q3 | $742K | Buy |
5,952
+325
| +6% | +$40.5K | 0.02% | 505 |
|
|
2020
Q2 | $503K | Buy |
+5,627
| New | +$503K | 0.01% | 604 |
|